A recent court case between a financial bank and a medical research company has made me reconsider some of the ways in which I view the world. I never really gave much thought to how medicine arrives on the drugstore’s shelves. But a recent story about a financial group, Laidlaw & Company, has made me appreciate just how complex an issue it can be. This is illustrated by the fact that they’re currently in a legal battle with Relmada Therapeutics. At the moment this has resulted in a temporary restraining order and associated injunction against Laidlaw. This is due to a ruling that Laidlaw might be spreading false or malicious information about Relmada.
What makes this case especially interesting is the simple fact that it’s so heavily tied into the creation and production of new therapies to treat chronic pain. It’s one of the more laudable goals that one could participate in. Obviously Relmada wants to get their products into people’s hands. And Laidlaw can be assumed to feel the same. But sometimes the world of business can derail even the most altruistic ideals.
To better understand the nature of their disagreement I looked into Laidlaw’s website. As far as the company itself goes, I was rather surprised to see just how established an institution it is. A company that has been around since 1842 is certainly doing something right. And the fact that they’ve had a great deal of international success also points to some wise decisions within the company.
But in the end it’s that decision making process which can best inform one’s opinion of a company. The people at the top who make the decisions are really the heart of an organization. For Laidlaw, that’s Matthew Eitner and James Ahern. I think one of the more notable aspects to them and to the company is the fact that both men are heavily featured within the site. They’re obviously proud of their work and happy to be associated with Laidlaw. And both men have a very impressive background. Not just within the business or financial sector either. In the end what made me like the company is the fact that both of them are also heavily involved with charity and similar endeavors. It’s a human side that makes me think that the company is trying to do the right thing.